Jason Bednar

Andrew Brackmann

Thomas Vranken

Mark Massaro

Thomas Flaten

Dan Brennan

Daniel Brennan

Nelson Cox

Vidyun Bais

- MDxHealth SA announced the **closing of its acquisition of the ExoDx business** from Bio-Techne Corporation on **September 15, 2025**.  **[1872529_0001213900-25-087816_ea025743501ex99-1_mdxhealth.htm:0]** 
- The acquisition, which includes the **ExoDx Prostate test** and related assets, has a total consideration of **$15 million**.  **[1872529_0001213900-25-087816_ea025743501ex99-1_mdxhealth.htm:0]** 
- The payment structure involves **$5 million in stock paid at closing** and **$2.5 million annually over the next four years**, with 50% in cash and 50% in cash or stock at MDxHealth’s discretion.  **[1872529_0001213900-25-087816_ea025743501ex99-1_mdxhealth.htm:0]**

MDxHealth Announces Closing of ExoDx Diagnostics Acquisition

MDxHealth (MDXH)